These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19857774)

  • 1. Controversial points in organ donor management.
    Chamorro C; Falcón JA; Michelena JC
    Transplant Proc; 2009 Oct; 41(8):3473-5. PubMed ID: 19857774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management to optimize organ procurement in brain dead donors.
    Mascia L; Mastromauro I; Viberti S; Vincenzi M; Zanello M
    Minerva Anestesiol; 2009 Mar; 75(3):125-33. PubMed ID: 18636057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine vasopressin versus desmopressin for the treatment of diabetes insipidus in the brain dead organ donor.
    Debelak L; Pollak R; Reckard C
    Transplant Proc; 1990 Apr; 22(2):351-2. PubMed ID: 2326913
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of triiodothyronine and vasopressin on cardiac function and myocardial blood flow after brain death.
    Meyers CH; D'Amico TA; Peterseim DS; Jayawant AM; Steenbergen C; Sabiston DC; Van Trigt P
    J Heart Lung Transplant; 1993; 12(1 Pt 1):68-79; discussion 79-80. PubMed ID: 8443205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive pharmacologic donor management results in more transplanted organs.
    Rosendale JD; Kauffman HM; McBride MA; Chabalewski FL; Zaroff JG; Garrity ER; Delmonico FL; Rosengard BR
    Transplantation; 2003 Feb; 75(4):482-7. PubMed ID: 12605114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A valid experimental brain death organ donor model.
    Bittner HB; Kendall SW; Campbell KA; Montine TJ; Van Trigt P
    J Heart Lung Transplant; 1995; 14(2):308-17. PubMed ID: 7779850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ protective management of the brain-dead donor.
    Saner FH; Kavuk I; Lang H; Radtke A; Paul A; Broelsch CE
    Eur J Med Res; 2004 Oct; 9(10):485-90. PubMed ID: 15546816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain death and its influence on the lungs of the donor: how is it prevented?
    Faropoulos K; Apostolakis E
    Transplant Proc; 2009 Dec; 41(10):4114-9. PubMed ID: 20005351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal resuscitation yields more transplanted hearts, with improved early function.
    Rosendale JD; Kauffman HM; McBride MA; Chabalewski FL; Zaroff JG; Garrity ER; Delmonico FL; Rosengard BR
    Transplantation; 2003 Apr; 75(8):1336-41. PubMed ID: 12717226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic changes during brain stem death--lessons for management of the organ donor.
    Smith M
    J Heart Lung Transplant; 2004 Sep; 23(9 Suppl):S217-22. PubMed ID: 15381167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammation in the brain-dead organ donor.
    Barklin A
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):425-35. PubMed ID: 19226294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive organ donor management protocol.
    DuBose J; Salim A
    J Intensive Care Med; 2008; 23(6):367-75. PubMed ID: 18815202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adequate preservation of organs in brain-dead patients with a view to transplantation].
    Speelberg B; van Puyenbroek MJ
    Ned Tijdschr Geneeskd; 1997 Jun; 141(25):1234-7. PubMed ID: 9380166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine changes in brain death and transplantation.
    Ranasinghe AM; Bonser RS
    Best Pract Res Clin Endocrinol Metab; 2011 Oct; 25(5):799-812. PubMed ID: 21925079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of brain death on myocardial function and ischemic tolerance of potential donor hearts.
    Szabó G; Sebening C; Hackert T; Hagl C; Tochtermann U; Vahl CF; Hagl S
    J Heart Lung Transplant; 1998 Sep; 17(9):921-30. PubMed ID: 9773866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does diabetes insipidus in brain dead organ donors protect acute tubular necrosis in renal grafts?
    Rabanal JM; Teja JL; Quesada A; Cotorruelo J
    Transplant Proc; 1993 Dec; 25(6):3143. PubMed ID: 8266490
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy.
    Jeevanandam V; Todd B; Regillo T; Hellman S; Eldridge C; McClurken J
    J Heart Lung Transplant; 1994; 13(4):681-7; discussion 685-7. PubMed ID: 7947885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gradual onset brain death model: a relevant model to study organ donation and its consequences on the outcome after transplantation.
    Kolkert JL; 't Hart NA; van Dijk A; Ottens PJ; Ploeg RJ; Leuvenink HG
    Lab Anim; 2007 Jul; 41(3):363-71. PubMed ID: 17640464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain death and its implications for management of the potential organ donor.
    Bugge JF
    Acta Anaesthesiol Scand; 2009 Nov; 53(10):1239-50. PubMed ID: 19681785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain death: epidemiology and quality control of solid organ donor generation.
    Mizraji R; Pérez S; Alvarez I
    Transplant Proc; 2004; 36(6):1641-4. PubMed ID: 15350439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.